Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Clinical trial NCT00675350 · COMPLETED

Trial details

NCT number: NCT00675350
Sponsor: ChemGenex Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Tumors

Start date: 2008-04-01
Primary completion: 2008-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.